我要投票 香雪XPH在医疗器械行业中的票数:262
· 外 推 电 报 ·
2025-06-21 08:59:46 星期六

【香雪XPH是哪个国家的品牌?】

香雪XPH是什么牌子?「香雪XPH」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人王董在1986年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪XPH品牌出海!将品牌入驻外推网,定制香雪XPH品牌推广信息,可以显著提高香雪XPH产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

广州市香雪制药股份有限公司,始于1986年,广东省名牌,药典标准制定者,大中药健康产业领先者,现代化高新技术医药企业


“十里梅花浑似雪,萝岗香雪映朝阳。”诗人郭沫若赋诗赞赏的羊城八景之一“萝岗香雪”, 正是香雪制药的发祥地。1986年萝岗制药厂成立,1997年改制为广州市香雪制药股份有限公司,于2010年在中国深圳证券交易所公开发行股票(IPO)挂牌上市(股票代码:300147)。秉承“厚生、臻善、维新”的经营理念,公司把发展中药和实现中药现代化作为长远发展战略,经多年发展,现已成为拥有自主知识产权、自主品牌、自主创新能力的中药现代化的领军企业和技术企业,形成中药资源开发、中药先进制造、现代物流配送、新药创制的完整产业链。香雪制药先后在广东、北京、山西、四川、重庆、安徽、云南和宁夏等地设立十八间公司并投资兴建大规模的GMP生产基地和GAP药材种植基地,形成了新型中药饮片、中成药、功能健康食品(饮料)、养生保健等产品群所组成的大中药健康产业,在中国创造就业职位一万余个。

数字化中药

香雪制药致力于中药现代化的研究和实践,在中药现代化的关键技术——中成药质量控制技术、现代制剂技术、中药给药途径创新等研究取得丰硕成果及突破。香雪制药建立了以“现代中药指纹图谱质量控制技术”为核心的现代中药集成创新系统,应用指纹图谱质控技术,通过计算机相似度分析系统使得成分复杂的中药质量得到有效控制;应用中药临床循证医学评价方法,通过大样品、多中心的大规模临床数据评价使中药疗效准确与经济。香雪制药引进全球先进的信息管理系统,使中药生产经营、销售服务过程实现全面信息资源管理,对企业资源、供应链、客户关系、节能环保、智能办公等方面完成高度集成,使中药企业管理与大数据时代接轨。


英文翻译:Guangzhou Xiangxue Pharmaceutical Co., Ltd. started in 1986. It is a famous brand in Guangdong Province, a standard maker of Pharmacopoeia, a leader in the health industry of traditional Chinese medicine, and a modern high-tech pharmaceutical enterprise Luogang Xiangxue, one of the eight sceneries in Yangcheng, is the birthplace of Xiangxue pharmaceutical. Luogang pharmaceutical factory was established in 1986, and was restructured into Guangzhou Xiangxue Pharmaceutical Co., Ltd. in 1997. It was listed on the Shenzhen Stock Exchange in 2010 (Stock Code: 300147). Adhering to the business philosophy of "health, perfection and renovation", the company takes the development of traditional Chinese medicine and the modernization of traditional Chinese medicine as its long-term development strategy. After years of development, the company has become a leading enterprise and technical enterprise with independent intellectual property rights, independent brand and independent innovation ability, forming the development of traditional Chinese medicine resources, advanced manufacturing of traditional Chinese medicine, modern logistics and distribution, and the creation of new drugs A complete industrial chain. Xiangxue pharmaceutical has successively set up 18 companies in Guangdong, Beijing, Shanxi, Sichuan, Chongqing, Anhui, Yunnan and Ningxia and invested in the construction of large-scale GMP production base and gap medicine planting base, forming a large traditional Chinese medicine health industry composed of new traditional Chinese medicine pieces, proprietary Chinese medicine, functional health food (beverage), health care and other product groups, creating jobs in China More than 10000. Xiangxue pharmaceutical is committed to the research and practice of the modernization of traditional Chinese medicine, and has made fruitful achievements and breakthroughs in the key technologies of the modernization of traditional Chinese medicine, such as the quality control technology of traditional Chinese medicine, the modern preparation technology, and the innovation of the way of administration of traditional Chinese Medicine. Xiangxue pharmaceutical has established a modern integrated innovation system of traditional Chinese medicine with "modern fingerprint quality control technology" as the core. By using fingerprint quality control technology and computer similarity analysis system, the quality of traditional Chinese medicine with complex components can be effectively controlled. By using the clinical evidence-based medicine evaluation method of traditional Chinese medicine, the quality of traditional Chinese medicine can be effectively controlled through large-scale clinical data evaluation of large samples and multi centers The therapeutic effect is accurate and economical. Xiangxue pharmaceutical introduced the world's advanced information management system to realize the comprehensive information resource management in the process of Chinese medicine production, operation and sales service, and highly integrated the enterprise resources, supply chain, customer relationship, energy conservation and environmental protection, intelligent office, etc., so as to make the Chinese medicine enterprise management in line with the big data era.

本文链接: https://www.waitui.com/brand/5a03ebbad.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美联储理事沃勒:或许最早在七月会议上就可能降息

据报道,美联储理事沃勒表示,或许最早在七月会议上就可能降息。(第一财经)

60分钟前

美股大型科技股盘前多数上涨,特斯拉涨超1%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,特斯拉涨超1%,Arm涨0.68%,亚马逊涨0.59%,Meta涨0.39%,苹果涨0.37%,微软涨0.12%;英伟达跌0.02%。

60分钟前

热门中概股美股盘前涨跌不一,蔚来涨超1%

36氪获悉,热门中概股美股盘前涨跌不一,截至发稿,蔚来涨超1%,阿里巴巴、网易涨近1%,爱奇艺涨0.59%;京东、拼多多跌近1%,B站跌0.52%,理想汽车跌0.08%,小鹏汽车跌0.05%。

60分钟前

朗特智能:控股股东欧阳正良拟询价转让650.9万股,占总股本4.5%

36氪获悉,朗特智能公告,公司控股股东、实际控制人、董事长欧阳正良计划询价转让650.9万股,占公司总股本的4.5%,转让原因为自身资金需求。出让方承诺所持股份权属清晰,不存在限制或禁止转让情形。转让不通过集中竞价交易或大宗交易方式进行,受让方在受让后6个月内不得转让。参与询价转让的投资者需具备相应定价能力和风险承受能力。

60分钟前

杰美特:筹划以现金方式购买思腾合力控制权,可能构成重大资产重组

36氪获悉,杰美特公告,公司正在筹划以现金方式购买思腾合力(天津)科技有限公司控制权,交易价格及收购比例待进一步论证和协商。本次交易完成后,思腾合力将成为公司控股子公司。根据初步测算,本次交易可能构成重大资产重组。本次交易拟采用现金方式,不涉及公司发行股份,不构成关联交易,也不会导致上市公司控制权的变更。

60分钟前

本页详细列出关于香雪XPH的品牌信息,含品牌所属公司介绍,香雪XPH所处行业的品牌地位及优势。
咨询